SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-020853
Filing Date
2020-10-07
Accepted
2020-10-07 16:35:42
Documents
14
Period of Report
2020-10-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20201007_8k.htm   iXBRL 8-K 23115
6 mbrx20201007_8kimg001.jpg GRAPHIC 3620
  Complete submission text file 0001437749-20-020853.txt   169406

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20201002.xsd EX-101.SCH 3700
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20201002_def.xml EX-101.DEF 11972
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20201002_lab.xml EX-101.LAB 16010
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20201002_pre.xml EX-101.PRE 12181
7 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20201007_8k_htm.xml XML 2656
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 201229430
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences